Advertisement

Radiofrequency Ablation for Hepatocellular Carcinoma

  • E. Ramsay Camp
  • Nestor F. Esnaola
  • Steven A. Curley
Chapter

Abstract

Hepatocellular carcinoma (HCC) is the most frequent primary hepatic tumor and the fifth most common cancer worldwide. The incidence continues to rise worldwide due to its association with hepatitis B and C viral infections. Cirrhosis is present concurrently with HCC in approximately 90% of the identified cases [1, 2]. Furthermore, the incidence of HCC increases with the severity of cirrhosis. Follow-up studies have identified HCC as one of the most common causes of death in the cirrhotic patient [3, 4]. The management of HCC, therefore, is based both on the stage of the malignancy and on the underlying functional status of the liver. Local tumor ablative techniques remain a reasonable treatment consideration for patients with disease confined to the liver who are not candidates for resection or transplantation.

Keywords

Radiofrequency ablation HCC treatment strategy Open RFA laparoscopic RFA RFA outcomes HCC 

References

  1. 1.
    Bruix J, Boix L, Sala M, Llovet JM (2004) Focus on hepatocellular carcinoma. Cancer Cell 5:215–219CrossRefPubMedGoogle Scholar
  2. 2.
    Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127(5 Suppl 1):S35–S50CrossRefPubMedGoogle Scholar
  3. 3.
    Degos F, Christidis C, Ganne-Carrie N et al Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47:131–136.Google Scholar
  4. 4.
    Benvegnu L, Gios M, Boccato S, Alberti A (2004) Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53:744–749CrossRefPubMedGoogle Scholar
  5. 5.
    Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43CrossRefPubMedGoogle Scholar
  6. 6.
    Duffy JP, Vardanian A, Benjamin E et al (2007) Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246:502–509CrossRefPubMedGoogle Scholar
  7. 7.
    Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669–1677CrossRefPubMedGoogle Scholar
  8. 8.
    Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Yamashita Y, Maehara Y (2008) Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 15:124–130CrossRefPubMedGoogle Scholar
  9. 9.
    Georgiades CS, Hong K, Geschwind JF (2008) Radiofrequency ablation and chemoembolization for hepatocellular carcinoma. Cancer J 14:117–122CrossRefPubMedGoogle Scholar
  10. 10.
    Curley SA (2003) Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 10:338–347CrossRefPubMedGoogle Scholar
  11. 11.
    Curley SA, Izzo F, Delrio P et al (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230:1–8CrossRefPubMedGoogle Scholar
  12. 12.
    Choi H, Loyer EM, DuBrow RA et al (2001) Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics 21 Spec No:S41–S54PubMedGoogle Scholar
  13. 13.
    Paudyal B, Oriuchi N, Paudyal P et al (2007) Early diagnosis of recurrent hepatocellular carcinoma with 18F-FDG PET after radiofrequency ablation therapy. Oncol Rep 18:1469–1473PubMedGoogle Scholar
  14. 14.
    Langenhoff BS, Oyen WJ, Jager GJ et al (2002) Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20:4453–4458CrossRefPubMedGoogle Scholar
  15. 15.
    Barker DW, Zagoria RJ, Morton KA, Kavanagh PV, Shen P (2005) Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. AJR Am J Roentgenol 184:1096–1102PubMedGoogle Scholar
  16. 16.
    Travaini LL, Trifiro G, Ravasi L et al (2008) Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results. Eur J Nucl Med Mol Imaging 35:1316–1322CrossRefPubMedGoogle Scholar
  17. 17.
    Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P (2000) Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232:381–391CrossRefPubMedGoogle Scholar
  18. 18.
    Raut CP, Izzo F, Marra P et al (2005) Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12:616–628CrossRefPubMedGoogle Scholar
  19. 19.
    Lam VW, Ng KK, Chok KS et al (2008) Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 207:20–29CrossRefGoogle Scholar
  20. 20.
    Lencioni R, Cioni D, Crocetti L et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–967CrossRefPubMedGoogle Scholar
  21. 21.
    Montorsi M, Santambrogio R, Bianchi P et al (2005) Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 9:62–67CrossRefPubMedGoogle Scholar
  22. 22.
    Chen MS, Li JQ, Zheng Y et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328CrossRefPubMedGoogle Scholar
  23. 23.
    Choi D, Lim HK, Rhim H et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692CrossRefPubMedGoogle Scholar
  24. 24.
    Poon RT, Ng KK, Lam CM, Ai V, Yuen J, Fan ST (2004) Effectiveness of radiofrequency ablation for hepatocellular carcinomas larger than 3 cm in diameter. Arch Surg 139:281–287CrossRefPubMedGoogle Scholar
  25. 25.
    Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7:593–600PubMedGoogle Scholar
  26. 26.
    Vivarelli M, Guglielmi A, Ruzzenente A et al (2004) Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver. Ann Surg 240:102–107CrossRefPubMedGoogle Scholar
  27. 27.
    Choi D, Lim HK, Joh JW et al (2007) Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol 14:3510–3518CrossRefPubMedGoogle Scholar
  28. 28.
    Onik GM, Atkinson D, Zemel R, Weaver ML (1993) Cryosurgery of liver cancer. Semin Surg Oncol 9:309–317CrossRefPubMedGoogle Scholar
  29. 29.
    Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235–240CrossRefPubMedGoogle Scholar
  30. 30.
    Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127:1714–1723CrossRefPubMedGoogle Scholar
  31. 31.
    Shiina S, Teratani T, Obi S et al (2005) A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 129:122–130CrossRefPubMedGoogle Scholar
  32. 32.
    Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699CrossRefPubMedGoogle Scholar
  33. 33.
    Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–1440CrossRefPubMedGoogle Scholar
  34. 34.
    Figueras J, Ibanez L, Ramos E et al (2001) Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 7:877–883CrossRefPubMedGoogle Scholar
  35. 35.
    Mazzaferro V, Battiston C, Perrone S et al (2004) Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 240:900–909CrossRefPubMedGoogle Scholar
  36. 36.
    Brillet PY, Paradis V, Brancatelli G et al (2006) Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. AJR Am J Roentgenol 186(5 Suppl):S296–S305CrossRefPubMedGoogle Scholar
  37. 37.
    Lu DS, Yu NC, Raman SS et al (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41:1130–1137CrossRefPubMedGoogle Scholar
  38. 38.
    Fisher RA, Maluf D, Cotterell AH et al (2004) Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 18:502–512CrossRefPubMedGoogle Scholar
  39. 39.
    Mazzaferro V, Chun YS, Poon RT et al (2008) Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 15:1001–1007CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • E. Ramsay Camp
    • 1
  • Nestor F. Esnaola
    • 1
  • Steven A. Curley
    • 2
  1. 1.Department of SurgeryMedical University of South CarolinaCharlestonUSA
  2. 2.Department of Surgical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations